May 11, 2026 04:01PM
Feb 9, 2026 04:01PM
Jan 9, 2026 03:09AM
Jan 8, 2026 07:07AM
Jan 8, 2026 07:00AM
Nov 17, 2025 04:01PM
Nov 14, 2025 02:39AM JPMorgan Starts Enanta Pharmaceuticals (ENTA) at Overweight
Sep 30, 2025 04:20AM
Sep 29, 2025 06:30AM
Sep 29, 2025 06:30AM
Aug 11, 2025 04:02PM
Aug 6, 2025 07:56PM
Jun 11, 2025 12:34PM
Jun 11, 2025 12:34PM Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C
May 12, 2025 04:01PM
Feb 10, 2025 04:01PM
Dec 9, 2024 06:32AM
Dec 9, 2024 06:30AM
Dec 6, 2024 05:00PM
Nov 25, 2024 04:01PM
Sep 26, 2024 06:02AM Enanta Pharma (ENTA) Reports Positive Topline Results for EDP-323
Sep 26, 2024 06:00AM
Jan 4, 2024 07:00AM
Nov 20, 2023 04:01PM
Aug 7, 2023 04:01PM
Jun 20, 2023 07:00AM
Jun 20, 2023 07:00AM
Apr 6, 2023 07:01AM Enanta Pharma (ENTA) Granted FDA Fast Track Designation for EDP-323
Apr 6, 2023 07:00AM
Jan 6, 2023 07:00AM
Nov 21, 2022 04:02PM
Nov 9, 2022 07:00AM
Oct 3, 2022 07:00AM
Aug 8, 2022 04:03PM
Aug 8, 2022 04:00PM Enanta Pharma (ENTA) Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer
Aug 8, 2022 04:00PM
Jul 29, 2022 07:00AM
Jul 29, 2022 07:00AM
May 18, 2022 04:01PM
May 18, 2022 04:01PM
May 9, 2022 04:01PM
Mar 29, 2022 07:00AM Enanta Pharma (ENTA) Granted FDA Fast Track Designation for EDP-235
Mar 29, 2022 07:00AM
Feb 17, 2022 07:03AM
Feb 17, 2022 07:00AM
Feb 8, 2022 04:01PM
Jan 6, 2022 07:00AM
Oct 4, 2021 07:06AM
Oct 4, 2021 07:00AM Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs
Jan 8, 2021 07:06AM

322,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All